Okamura N - Search Results

1

Cerebrospinal Fluid Clearance in Alzheimer Disease Measured with Dynamic PET.

de Leon MJ, Li Y, Okamura N, Tsui WH, Saint-Louis LA, Glodzik L, Osorio RS, Fortea J, Butler T, Pirraglia E, Fossati S, Kim HJ, Carare RO, Nedergaard M, Benveniste H, Rusinek H. de Leon MJ, et al. Among authors: okamura n. J Nucl Med. 2017 Sep;58(9):1471-1476. doi: 10.2967/jnumed.116.187211. Epub 2017 Mar 16. J Nucl Med. 2017. PMID: 28302766 Free PMC article.

2

Cerebrospinal fluid levels of amyloid beta-peptide1-42, but not tau have positive correlation with brain glucose metabolism in humans.

Okamura N, Arai H, Higuchi M, Tashiro M, Matsui T, Itoh M, Iwatsubo T, Tomita T, Sasaki H. Okamura N, et al. Neurosci Lett. 1999 Oct 8;273(3):203-7. doi: 10.1016/s0304-3940(99)00644-8. Neurosci Lett. 1999. PMID: 10515194

3

Quinoline and benzimidazole derivatives: candidate probes for in vivo imaging of tau pathology in Alzheimer's disease.

Okamura N, Suemoto T, Furumoto S, Suzuki M, Shimadzu H, Akatsu H, Yamamoto T, Fujiwara H, Nemoto M, Maruyama M, Arai H, Yanai K, Sawada T, Kudo Y. Okamura N, et al. J Neurosci. 2005 Nov 23;25(47):10857-62. doi: 10.1523/JNEUROSCI.1738-05.2005. J Neurosci. 2005. PMID: 16306398 Free PMC article.

4

[Alzheimer' s disease].

Okamura N, Furumoto S, Kudo Y, Yanai K. Okamura N, et al. Nihon Rinsho. 2007 Feb;65(2):320-6. Nihon Rinsho. 2007. PMID: 17302278 Review. Japanese.

5

2-(2-[2-Dimethylaminothiazol-5-yl]ethenyl)-6- (2-[fluoro]ethoxy)benzoxazole: a novel PET agent for in vivo detection of dense amyloid plaques in Alzheimer's disease patients.

Kudo Y, Okamura N, Furumoto S, Tashiro M, Furukawa K, Maruyama M, Itoh M, Iwata R, Yanai K, Arai H. Kudo Y, et al. Among authors: okamura n. J Nucl Med. 2007 Apr;48(4):553-61. doi: 10.2967/jnumed.106.037556. J Nucl Med. 2007. PMID: 17401091 Free article.

6

In vivo detection of prion amyloid plaques using [(11)C]BF-227 PET.

Okamura N, Shiga Y, Furumoto S, Tashiro M, Tsuboi Y, Furukawa K, Yanai K, Iwata R, Arai H, Kudo Y, Itoyama Y, Doh-ura K. Okamura N, et al. Eur J Nucl Med Mol Imaging. 2010 May;37(5):934-41. doi: 10.1007/s00259-009-1314-7. Epub 2009 Dec 17. Eur J Nucl Med Mol Imaging. 2010. PMID: 20016895 Clinical Trial.

7

[Molecular PET imaging for in vivo detection of amyloid in the human brain].

Okamura N. Okamura N. Rinsho Shinkeigaku. 2009 Nov;49(11):922-4. doi: 10.5692/clinicalneurol.49.922. Rinsho Shinkeigaku. 2009. PMID: 20030249 Review. Japanese.

8

A modified method of 3D-SSP analysis for amyloid PET imaging using [¹¹C]BF-227.

Kaneta T, Okamura N, Minoshima S, Furukawa K, Tashiro M, Furumoto S, Iwata R, Fukuda H, Takahashi S, Yanai K, Kudo Y, Arai H. Kaneta T, et al. Among authors: okamura n. Ann Nucl Med. 2011 Dec;25(10):732-9. doi: 10.1007/s12149-011-0518-7. Epub 2011 Jul 27. Ann Nucl Med. 2011. PMID: 21792587 Clinical Trial.

9

Comparison of the binding characteristics of [18F]THK-523 and other amyloid imaging tracers to Alzheimer's disease pathology.

Harada R, Okamura N, Furumoto S, Tago T, Maruyama M, Higuchi M, Yoshikawa T, Arai H, Iwata R, Kudo Y, Yanai K. Harada R, et al. Among authors: okamura n. Eur J Nucl Med Mol Imaging. 2013 Jan;40(1):125-32. doi: 10.1007/s00259-012-2261-2. Epub 2012 Oct 26. Eur J Nucl Med Mol Imaging. 2013. PMID: 23100049

10

Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease.

Okamura N, Furumoto S, Harada R, Tago T, Yoshikawa T, Fodero-Tavoletti M, Mulligan RS, Villemagne VL, Akatsu H, Yamamoto T, Arai H, Iwata R, Yanai K, Kudo Y. Okamura N, et al. J Nucl Med. 2013 Aug;54(8):1420-7. doi: 10.2967/jnumed.112.117341. Epub 2013 Jul 15. J Nucl Med. 2013. PMID: 23857514 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

673 results

Search Page